Atlas Trials

Surveillance Study to Estimate the Incidence of Pure Red Blood Cell Aplasia Among Patients With Chronic Kidney Failure

Clinical trial NCT00391287 · COMPLETED

Trial details

NCT number
NCT00391287
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status
COMPLETED
Study type
OBSERVATIONAL
Pure Red-Cell AplasiaChronic Kidney Failure
Start date
2006-06-01
Primary completion
2010-12-01
Enrollment
15334

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.